Z. FARID, M.D.; B. TRABOLSI, M.D.; M. STEK, M.D.
To the editor: Last year, in commenting on a review article on praziquantel published in your journal (1), we reported excellent results obtained by treating Schistosoma haematobium infection in children with a single oral dose of 30 mg/kg body weight (2). Indeed, this low dose was subsequently also found to be adequate in relieving urinary obstructive lesions caused by S. haematobium infection (3). In the same letter, we emphasized the unsuccessful treatment of S. mansoni infection in Egyptian children with praziquantel, even when using a higher single dose of 40 mg/kg body weight; instead, we suggested treating them with three
FARID Z, TRABOLSI B, STEK M. Schistosomiasis and Praziquantel. Ann Intern Med. ;101:882. doi: 10.7326/0003-4819-101-6-882_1
Download citation file:
Published: Ann Intern Med. 1984;101(6):882.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use